This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA panel backs Moderna half dose booster for high risk groups
U S health advisers unanimously recommended a half dose Moderna booster for seniors and younger adults with health risks six months after initial vaccination. The nonbinding vote supports expanding boosters for high risk populations while experts caution against a universal rollout.
MENTIONED IN THIS ARTICLE
U.S
Food and Drug Administration
FDA
Michael Kurilla
National Institutes of Health
Moderna
Johnson & Johnson
J&j
Centers For Disease Control and Prevention
USS
Israel
Pfizer
Sharon Alroy-Press
Health Ministry
Alroy-Press